Order Article Reprints

Banella C, Catalano G, Travaglini S, Pelosi E, Ottone T, Zaza A, Guerrera G, Angelini DF, Niscola P, Divona M, et al. Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment. Cancers. 2022; 14(10):2565. https://doi.org/10.3390/cancers14102565

Banella, Cristina, Gianfranco Catalano, Serena Travaglini, Elvira Pelosi, Tiziana Ottone, Alessandra Zaza, Gisella Guerrera, Daniela Francesca Angelini, Pasquale Niscola, Mariadomenica Divona, and et al. 2022. "Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment" Cancers 14, no. 10: 2565. https://doi.org/10.3390/cancers14102565

Banella, C., Catalano, G., Travaglini, S., Pelosi, E., Ottone, T., Zaza, A., Guerrera, G., Angelini, D. F., Niscola, P., Divona, M., Battistini, L., Screnci, M., Ammatuna, E., Testa, U., Nervi, C., Voso, M. T., & Noguera, N. I. (2022). Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment. Cancers, 14(10), 2565. https://doi.org/10.3390/cancers14102565